Enterprise Financial Services Corp (EFSC)’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-23
Closed -$1K 782
2021
Q2
$1K Buy
23
+12
+109% +$470 ﹤0.01% 1242
2021
Q1
$0 Hold
11
﹤0.01% 1384
2020
Q4
$1K Hold
11
﹤0.01% 1211
2020
Q3
$1K Hold
11
﹤0.01% 1184
2020
Q2
$1K Hold
11
﹤0.01% 1195
2020
Q1
$1K Sell
11
-89
-89% -$4.96K ﹤0.01% 1162
2019
Q4
$6K Hold
100
﹤0.01% 822
2019
Q3
$6K Hold
100
﹤0.01% 817
2019
Q2
$6K Hold
100
﹤0.01% 857
2019
Q1
$8K Buy
+100
New +$6.45K ﹤0.01% 793
2016
Q1
Sell
-105
Closed -$7K 1095
2015
Q4
$7K Buy
+105
New +$5.67K ﹤0.01% 644

Other funds holding IONS

Enterprise Financial Services Corp (EFSC)'s IONS Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Ionis Pharmaceuticals (IONS) in Q3 2021, closing a stake of 23 shares — an estimated $1K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in IONS in Q4 2015 and held it in 11 quarters. The position peaked at $8K in Q1 2019. 324 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Ionis Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 23 Ionis Pharmaceuticals shares in Q3 2021, an estimated $1K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 11 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Ionis Pharmaceuticals position peaked at $8K in Q1 2019.
  • 324 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.